Resources

News

 

Case Studies

Webinars & Presentations

Engineering Human Antibodies Discovered with AlivaMab® Mouse into a Dual-Antagonist Bispecific Antibody Therapeutic

Biologics UK 2022

WATCH

Upcoming Events

Antibody Therapeutics Xchange East Coast

May 16, 2022

Learn More

Antibody Engineering & Therapeutics Europe

June 7-9, 2022

Learn More

Features & Interviews

Profile from Nature’s BioPharma Dealmakers September 2021

Ablexis and AlivaMab Discovery Services. Unparalleled success in antibody discovery and development.

DOWNLOAD

Pharmaceutical Executive speaks with Larry Green

From Mouse to Mab

READ

Nature speaks to Larry Green, Founder and Executive Chairman

Harnessing platform technology and expertise to fuel antibody drug discovery

DOWNLOAD